About Hepatocellular Carcinoma Stage C

Overview

Hepatocellular carcinoma (HCC) is a tumor that develops in the liver. The stage of liver cancer indicates the severity of the cancer and may help guide treatment. One common staging system is the Barcelona Clinic Liver Cancer (BCLC) criteria, which considers the whether the cancer has spread, how well the liver is working, the general health and wellness of the patient, and symptoms caused by the cancer.

Stage C HCC is considered advanced-stage HCC. Stage C HCC is characterized by the following:

  • Extensive multifocal disease: The cancer has spread to multiple areas within the liver.
  • No vascular invasion: There is no invasion of blood vessels by the cancer cells.
  • Preserved liver function: The liver is still functioning relatively well, with Child-Pugh classes A or B.
  • Absence of cancer-related symptoms: There are no symptoms directly caused by the cancer.
  • Varying tumor sizes (larger than 3cm to over 10cm) and numbers (2 to over 20)

The recommended treatment for Stage C HCC, according to the BCLC algorithm, is transarterial chemoembolization (TACE). However, treatment options may vary depending on individual factors. It's best to consult with a healthcare professional for personalized advice and treatment recommendations.

Causes and Risk Factors

Hepatocellular Carcinoma (HCC) is caused genetic changes in DNA can be inherited from parents or acquired due to irregularities during cell division.

Non-modifiable risk factors (factors a person cannot change or control) for HCC include:

  • History of primary sclerosing cholangitis and inflammatory bowel disease.
  • Geographic risk factors such as liver fluke infections in Southeastern Asia.

Modifiable risk factors (factors a person potentially could change or control) for HCC include:

  • Chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection
  • Excessive alcohol consumption
  • Smoking
  • Obesity, especially abdominal obesity
  • Type 2 diabetes
  • Consumption of a diet high in red meat, saturated fat, cholesterol, and sugar. It should be noted that a diet rich in n-3 polyunsaturated fatty acids, fish and poultry, vegetables, and fiber is inversely associated with HCC risk (decreases risk)

It's important to note that these risk factors are associated with the development of HCC in general, not specifically HCC Stage C. Having risk factors does not guarantee the development of HCC.

Lifestyle modifications, such as reducing alcohol intake and maintaining a healthy weight, may help reduce the risk of developing HCC. However, it's always recommended to consult with a healthcare professional for personalized advice and guidance.

Symptoms

In the early stages of HCC Stage 3, there may not be any obvious symptoms. However, as the cancer progresses or reaches a higher severity, the following symptoms may occur:

  • Abdominal pain
  • Anorexia (loss of appetite)
  • Dyspepsia (indigestion)
  • Jaundice (yellowing of the skin and eyes)
  • Dark urine
  • Pale stools
  • Itchy skin
  • Reduced appetite
  • Feeling full shortly after eating
  • Unintended weight loss
  • Nausea and vomiting
  • Abdominal swelling
  • Easy bruising or bleeding
  • Fever
  • Enlarged liver or spleen
  • High calcium levels in the blood
  • High red blood cell count
  • Low blood sugar

It's important to note that these symptoms can also be associated with other liver conditions, so it's essential to see a doctor for an accurate diagnosis.

Diagnosis

To diagnose and determine the stage of HCC Stage C, several examinations, tests, and procedures are commonly performed:

  • Physical exam: A health care provider will conduct a physical exam to look for physical signs of HCC, such as pain, swelling, or masses in the body.
  • Blood tests: These tests help assess liver function and overall health. Specific blood tests for HCC may include liver function tests, blood clotting tests, tests for hepatitis B and hepatitis C, and serum alpha-fetoprotein.
  • Imaging tests: These tests allow doctors to visualize the liver and identify suspicious areas. Common imaging tests for HCC include ultrasound, CT scan, and MRI scan.
  • Biopsy: While not always necessary for HCC diagnosis, a biopsy involves removing a tissue sample from the liver tumor to check for signs of cancer under a microscope. This can confirm the presence of HCC.

To determine the stage of HCC, additional examinations, tests, and procedures may be performed:

  • Additional imaging studies: In addition to the initial imaging tests, further imaging studies may be conducted to assess the extent of tumor spread and involvement of nearby structures.
  • Genetic testing: Additional tests can be done on the biopsy sample to further characterize the cancer and analyze its genetics.
  • Staging systems: There are several staging systems for HCC that help classify the disease based on factors like tumor size, number of tumors, involvement of blood vessels, and spread to nearby lymph nodes or distant organs.

It is important to consult with your health care provider who can recommend specific examinations, tests, and procedures based on your individual situation.

Treatment Options

The goals of treatment for HCC Stage C are to prolong survival and improve quality of life. The recommended treatments and therapies for HCC Stage C include:

  • Surgical resection: This involves removing the tumor and surrounding liver tissue. The goal is to eliminate the cancerous cells and prevent further spread. Surgical resection can potentially offer a long-term survival benefit in adequately selected patients.
  • Transarterial chemoembolization (TACE): This procedure delivers chemotherapy drugs directly to the tumor through the blood vessels supplying the liver. It also blocks these blood vessels, cutting off the tumor's blood supply. TACE can help shrink the tumor and slow down its growth.
  • Radiofrequency ablation (RFA): RFA uses heat energy to destroy cancer cells. It is performed by inserting a needle-like probe into the tumor and heating it to high temperatures. RFA can be an effective treatment option for small tumors.
  • Liver transplantation: In some cases, a liver transplant may be recommended for patients with HCC Stage C. This involves replacing the diseased liver with a healthy one from a donor.

In addition to these therapeutic procedures, health behavior changes such as maintaining a healthy weight, avoiding alcohol consumption, and getting vaccinated against hepatitis B are important in managing HCC Stage C.

Remember, treatment decisions should be made in consultation with your healthcare professional, as they can recommend the most appropriate options based on your individual situation. Medication dosing may be affected by many factors, so always check with your healthcare professional about dosing for your specific case. Side effects can occur, so it's important to discuss potential risks with your healthcare professional or refer to the information provided with your medication.